DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy
New genetic testing could spare 6,600 UK breast cancer patients annually from unnecessary chemotherapy while maintaining equivalent survival rates. International…
Editor's Top Picks
New Blood Tests and Stool Screens Join Colonoscopy as Primary Options for Colorectal Cancer Detection
The American Cancer Society updated colorectal cancer screening guidelines to include blood-based tests alongside colonoscopy and stool screening methods. The…
Submit Your Paper to GMJ
WOAH Calls for Global Phase-Out of Lead Hunting Ammunition to Protect Wildlife and Human Health
The World Organisation for Animal Health calls for global elimination of lead hunting ammunition, citing 10-20 million annual bird deaths…
Popular Anti-Aging Drug Combination Causes Severe Brain Damage in Mice
A widely researched anti-aging drug combination caused severe brain damage in mice, including myelin loss and cognitive changes resembling "chemo…
PAHO Partners with Mundo Sano Foundation to Eliminate Neglected Diseases and Cervical Cancer
PAHO and Argentina's Mundo Sano Foundation partner to eliminate neglected tropical diseases affecting 200 million people in the Americas. The…
Largest Clinical Trial Reveals Optimal Treatment for Rare Chiari Malformation
A nationwide clinical trial of 394 patients has provided definitive evidence for optimal surgical treatment of Chiari malformation and syringomyelia.…
Genomic instability fuels cancer resistance through newly identified cellular pathway
New research reveals how genomic instability in ovarian cancer activates the STING-WNT pathway, creating protective myofibroblasts that drive both immune…
UK Nursing Regulator Failed to Screen Criminal Records for 12 Years
The UK's nursing regulator admits to 12 years of systematic failures in reviewing criminal records for healthcare professionals. More than…
Zanidatamab Plus Chemotherapy Shows 56% Improvement in HER2+ Gastric Cancer
Zanidatamab plus chemotherapy reduced disease progression risk by 44% compared to trastuzumab in HER2-positive gastroesophageal cancer patients. The phase III…
New PET Tracer Successfully Detects Alpha-Synuclein in Living Brains for Parkinson’s Diagnosis
Revolutionary PET tracer [11C]MODAG-005 successfully detects alpha-synuclein protein aggregates in living brains, offering breakthrough potential for early Parkinson's disease diagnosis…